Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for hyperactivity and attention difficulties in kids and individuals. In Canada, its distribution is managed by Health Canada. This https://vyvanseincanada752387.canariblogs.com/vyvanse-in-canada-a-comprehensive-guide-58178860